Applications of Apostle Technologies

Apostle technologies have been applied in many world-class R&D studies, clinical laboratory settings, and public health response and surveillance. For a complete list of applications citing Apostle technologies, including publications and customer testimonials, see References.

Click the banner below for details of the citing articles.

As applied in:

Apostle technologies have been cited or discussed in the following publications.

Apostle technologies have been cited or used by scientists from the following organizations. Click to read more when there is a publication.

Government Agencies

Universities or Research Institutes

Medical Centers

Companies

Current Accreditations

History of Accreditations

Recognitions and Awards

A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.